风温肺热病是由于感受风热毒邪引起,主要病机是感受外邪,机体正气不足,引发正邪交争所致,常以高热、咳嗽、咳痰、胸痛等为主要临床特征。中医药治疗风温肺热病具有不良反应小、价格实惠等优势。何复东教授是第六批全国名老中医药专家学...风温肺热病是由于感受风热毒邪引起,主要病机是感受外邪,机体正气不足,引发正邪交争所致,常以高热、咳嗽、咳痰、胸痛等为主要临床特征。中医药治疗风温肺热病具有不良反应小、价格实惠等优势。何复东教授是第六批全国名老中医药专家学术经验工作指导老师,在治疗咳嗽、喘证、风温肺热病等呼吸系统疾病方面有很深的学术造诣。何氏肺炎方是何复东教授治疗风温肺热病痰热壅肺证的自拟方,由麻杏石甘汤与银翘散化裁而来,二者相合,意在肺热得清,肺气得复,宣降得宜,肺络得通,多管齐下,诸证自愈,共奏清热化痰、宣肺通络之功。Wind-warm lung-heat disease is caused by the feeling of wind-heat toxin, the main pathogenesis of which is the feeling of exogenous pathogenic factors, the lack of vital energy in the body, which leads to the conflict between vital energy and pathogenic factors, high Fever, cough, expectoration and chest pain were the main clinical features. TCM treatment of wind-warm lung-heat disease has the advantages of small adverse reactions, affordable and so on. Professor He Fudong is the sixth national famous old Chinese medicine expert with academic experience work instructor, in the treatment of cough, asthma syndrome, wind-warm lung heat disease and other respiratory diseases have deep academic attainments. His pneumonia prescription is a self-made prescription of Professor He Fudong in treating the syndrome of phlegm-heat accumulation in the lung due to wind-warm-lung-heat disease. It is derived from Maxingshigan decoction and Yinqiao powder, multi-pronged approach, self-healing syndrome, a total of heat-clearing phlegm, lung and collaterals.展开更多
目的评价痰热清注射液治疗社区获得性肺炎(CAP)(痰热阻肺证)的疗效及安全性。方法由2名研究人员分别独立通过计算机系统地检索并筛选从PubMed、Cochrane Central Register of Controlled Trials、中国期刊全文数据库(CNKI)、中国生物医...目的评价痰热清注射液治疗社区获得性肺炎(CAP)(痰热阻肺证)的疗效及安全性。方法由2名研究人员分别独立通过计算机系统地检索并筛选从PubMed、Cochrane Central Register of Controlled Trials、中国期刊全文数据库(CNKI)、中国生物医学文献数据库(CBMdisc)、万方数据库、维普中文期刊数据库建库至2018年8月公开发表的关于痰热清注射液治疗CAP(痰热阻肺证)的随机对照临床试验,同时检索纳入文献的参考文献。采用Jadad量表对纳入文献进行质量评价,采用RevMan5.3软件进行Meta分析。结果共纳入24篇文献,共2 017例受试者(西医常规治疗+痰热清注射液治疗组为1 015例,西医常规治疗组为1002例),Jadad量表评分7篇文献3分,17篇文献2分。Meta分析结果显示,痰热清注射液联合西医常规治疗CAP(痰热阻肺证)较西医常规治疗组可以提高总有效率(OR值为4.44,95%CI[3.28,6.01]),缩短退热时间(SMD值为-1.49,95%CI[-2.09,-0.90])、咳嗽消失时间(SMD值为-1.66,95%CI[-2.61,-0.72])、肺部啰音消失时间(SMD值为-1.38,95%CI[-2.26,-0.50]),提高胸部阴影消失率(OR值为5.36,95%CI[3.04,9.45]),降低CRP水平(SMD值为-0.91,95%CI[-1.62,-0.21])及住院时间(SMD值为-2.71,95%CI[-3.03,-2.38])。两组间不良反应(OR值为0.56,95%CI[0.31,1.04])差异无统计学意义。结论痰热清注射液联合西医常规治疗CAP(痰热阻肺证)可以提高临床疗效,合理使用具有较好的安全性。展开更多
文摘风温肺热病是由于感受风热毒邪引起,主要病机是感受外邪,机体正气不足,引发正邪交争所致,常以高热、咳嗽、咳痰、胸痛等为主要临床特征。中医药治疗风温肺热病具有不良反应小、价格实惠等优势。何复东教授是第六批全国名老中医药专家学术经验工作指导老师,在治疗咳嗽、喘证、风温肺热病等呼吸系统疾病方面有很深的学术造诣。何氏肺炎方是何复东教授治疗风温肺热病痰热壅肺证的自拟方,由麻杏石甘汤与银翘散化裁而来,二者相合,意在肺热得清,肺气得复,宣降得宜,肺络得通,多管齐下,诸证自愈,共奏清热化痰、宣肺通络之功。Wind-warm lung-heat disease is caused by the feeling of wind-heat toxin, the main pathogenesis of which is the feeling of exogenous pathogenic factors, the lack of vital energy in the body, which leads to the conflict between vital energy and pathogenic factors, high Fever, cough, expectoration and chest pain were the main clinical features. TCM treatment of wind-warm lung-heat disease has the advantages of small adverse reactions, affordable and so on. Professor He Fudong is the sixth national famous old Chinese medicine expert with academic experience work instructor, in the treatment of cough, asthma syndrome, wind-warm lung heat disease and other respiratory diseases have deep academic attainments. His pneumonia prescription is a self-made prescription of Professor He Fudong in treating the syndrome of phlegm-heat accumulation in the lung due to wind-warm-lung-heat disease. It is derived from Maxingshigan decoction and Yinqiao powder, multi-pronged approach, self-healing syndrome, a total of heat-clearing phlegm, lung and collaterals.
文摘目的评价痰热清注射液治疗社区获得性肺炎(CAP)(痰热阻肺证)的疗效及安全性。方法由2名研究人员分别独立通过计算机系统地检索并筛选从PubMed、Cochrane Central Register of Controlled Trials、中国期刊全文数据库(CNKI)、中国生物医学文献数据库(CBMdisc)、万方数据库、维普中文期刊数据库建库至2018年8月公开发表的关于痰热清注射液治疗CAP(痰热阻肺证)的随机对照临床试验,同时检索纳入文献的参考文献。采用Jadad量表对纳入文献进行质量评价,采用RevMan5.3软件进行Meta分析。结果共纳入24篇文献,共2 017例受试者(西医常规治疗+痰热清注射液治疗组为1 015例,西医常规治疗组为1002例),Jadad量表评分7篇文献3分,17篇文献2分。Meta分析结果显示,痰热清注射液联合西医常规治疗CAP(痰热阻肺证)较西医常规治疗组可以提高总有效率(OR值为4.44,95%CI[3.28,6.01]),缩短退热时间(SMD值为-1.49,95%CI[-2.09,-0.90])、咳嗽消失时间(SMD值为-1.66,95%CI[-2.61,-0.72])、肺部啰音消失时间(SMD值为-1.38,95%CI[-2.26,-0.50]),提高胸部阴影消失率(OR值为5.36,95%CI[3.04,9.45]),降低CRP水平(SMD值为-0.91,95%CI[-1.62,-0.21])及住院时间(SMD值为-2.71,95%CI[-3.03,-2.38])。两组间不良反应(OR值为0.56,95%CI[0.31,1.04])差异无统计学意义。结论痰热清注射液联合西医常规治疗CAP(痰热阻肺证)可以提高临床疗效,合理使用具有较好的安全性。
